Company profile: Nanosyn
1.1 - Company Overview
Company description
- Provider of integrated drug discovery services as a contract research organization, including medicinal chemistry, made-to-order focused compound libraries, hit-to-lead optimization, process chemistry, analytical, and screening and profiling services for drug discovery needs; specializing in design, synthesis, and analysis of small organic.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanosyn
Medical Science & Computing
HQ: United States
Website
- Description: Provider of advanced data analytics and AI to support health, human services, and public safety missions; enterprise digital modernization and system integration; and cloud adoption and infrastructure optimization to enhance performance, reduce costs, improve public health, strengthen research and IT capabilities, and optimize operational outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Science & Computing company profile →
AbbVie
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for pharmaceutical companies across small and large molecules and biologics. Offerings include aseptic fill-finish of parenteral vials and prefilled syringes; biologics and antibody-drug conjugate manufacturing; API process optimization, tech transfer, and analytical development; turnkey ophthalmic filling and packaging; hot melt extrusion to improve API solubility and bioavailability; and microbial fermentation for API process development and commercial manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AbbVie company profile →
Labcorp
HQ: United States
Website
- Description: Provider of laboratory testing and drug development services for physicians and patients, hospitals, managed care plans, employers, military, law enforcement, and biopharmaceutical companies. Offerings include genetic and oncology testing, Alzheimer’s blood-based biomarkers (pTau-217, Beta Amyloid 42/40 Ratio), Labcorp OnDemand self-ordered tests, and biopharma services supported by a global laboratory network and clinical data resources.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcorp company profile →
Medfiles
HQ: Finland
Website
- Description: Provider of full-service contract research organization (CRO) services for the pharma, biotech, food, and medical device industries; first private CRO in Finland and the largest by range of services, with operations across the Nordic and Baltic countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfiles company profile →
Tjoapack
HQ: The Netherlands
Website
- Description: Provider of contract pharmaceutical packaging services, offering innovative primary and secondary packaging for oral solid doses (blister packs, wallets, bottles) and injectables (pre-filled syringes, vials, ampoules); unit-dose solutions with barcode verification; custom blister design, foil printing and high-speed packaging; bottle packaging with tamper-proof and child-resistant features; handling small and large-scale batches.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tjoapack company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanosyn
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanosyn
2.2 - Growth funds investing in similar companies to Nanosyn
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanosyn
4.2 - Public trading comparable groups for Nanosyn
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →